How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study ; volume:161 ; number:3 ; day:1 ; month:2 ; year:2023 ; pages:525-538 ; date:2.2023
Journal of neuro-oncology ; 161, Heft 3 (1.2.2023), 525-538, 2.2023

Creator: Perwein, Thomas
Giese, Barbara
Nussbaumer, Gunther
Bueren, André von
Buiren, Miriam van
Benesch, Martin
Kramm, Christof Maria

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11060-023-04241-6

URN: urn:nbn:de:101:1-2410141129555.692472736068

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Perwein, Thomas
Giese, Barbara
Nussbaumer, Gunther
Bueren, André von
Buiren, Miriam van
Benesch, Martin
Kramm, Christof Maria
SpringerLink (Online service)

Other Objects (12)

How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study

Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma

Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients

Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity

Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review

Multifocal high-grade glioma radiotherapy safety and efficacy

Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]

A prognostic neural epigenetic signature in high-grade glioma

How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study

Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma

Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients

Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity

Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review

Multifocal high-grade glioma radiotherapy safety and efficacy

Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]

A prognostic neural epigenetic signature in high-grade glioma

How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study

Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma

Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients

Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity

Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review

Multifocal high-grade glioma radiotherapy safety and efficacy

Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]

A prognostic neural epigenetic signature in high-grade glioma

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study

Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma

Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients

Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity

Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity

Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review

Multifocal high-grade glioma radiotherapy safety and efficacy

Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]

A prognostic neural epigenetic signature in high-grade glioma

A prognostic neural epigenetic signature in high-grade glioma

How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study

Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma

Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients

Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity

Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity

Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review

Multifocal high-grade glioma radiotherapy safety and efficacy

Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]

A prognostic neural epigenetic signature in high-grade glioma

A prognostic neural epigenetic signature in high-grade glioma

How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study

Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma

Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients

Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity

Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity

Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review

Multifocal high-grade glioma radiotherapy safety and efficacy

Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]

A prognostic neural epigenetic signature in high-grade glioma

A prognostic neural epigenetic signature in high-grade glioma

Related objects

Reset password